2022 Brazilian Thoracic Association recommendations for long-term home oxygen therapy

Some chronic respiratory diseases can cause hypoxemia and, in such cases, long-term home oxygen therapy (LTOT) is indicated as a treatment option primarily to improve patient quality of life and life expectancy. Home oxygen has been used for more than 70 years, and support for LTOT is based on two s...

Full description

Saved in:

Bibliographic Details
Published in:	Jornal brasileiro de pneumologia Vol. 48; no. 5; p. e20220179
Main Authors:	Castellano, Maria Vera Cruz de Oliveira, Pereira, Luiz Fernando Ferreira, Feitosa, Paulo Henrique Ramos, Knorst, Marli Maria, Salim, Carolina, Rodrigues, Mauri Monteiro, Ferreira, Eloara Vieira Machado, Duarte, Ricardo Luiz de Menezes, Togeiro, Sonia Maria, Stanzani, Lícia Zanol Lorencini, Medeiros Júnior, Pedro, Schelini, Karime Nadaf de Melo, Coelho, Liana Sousa, Sousa, Thiago Lins Fagundes de, Almeida, Marina Buarque de, Alvarez, Alfonso Eduardo
Format:	Journal Article
Language:	English
Published:	Brazil Sociedade Brasileira de Pneumologia e Tisiologia 01-01-2022
Subjects:	Brazil Humans Hypoxia - therapy Oxygen Oxygen Inhalation Therapy - adverse effects Pulmonary Disease, Chronic Obstructive Quality of Life RESPIRATORY SYSTEM Brazil Oxygen inhalation therapy Oxygen Hipóxia Oxigenoterapia Atenção à saúde Hypoxia Delivery of health care Oxigênio
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Some chronic respiratory diseases can cause hypoxemia and, in such cases, long-term home oxygen therapy (LTOT) is indicated as a treatment option primarily to improve patient quality of life and life expectancy. Home oxygen has been used for more than 70 years, and support for LTOT is based on two studies from the 1980s that demonstrated that oxygen use improves survival in patients with COPD. There is evidence that LTOT has other beneficial effects such as improved cognitive function, improved exercise capacity, and reduced hospitalizations. LTOT is indicated in other respiratory diseases that cause hypoxemia, on the basis of the same criteria as those used for COPD. There has been an increase in the use of LTOT, probably because of increased life expectancy and a higher prevalence of chronic respiratory diseases, as well as greater availability of LTOT in the health care system. The first Brazilian Thoracic Association consensus statement on LTOT was published in 2000. Twenty-two years later, we present this updated version. This document is a nonsystematic review of the literature, conducted by pulmonologists who evaluated scientific evidence and international guidelines on LTOT in the various diseases that cause hypoxemia and in specific situations (i.e., exercise, sleep, and air travel). These recommendations, produced with a view to clinical practice, contain several charts with information on indications for LTOT, oxygen sources, accessories, strategies for improved efficiency and effectiveness, and recommendations for the safe use of LTOT, as well as a LTOT prescribing model.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	1806-3756 1806-3756
DOI:	10.36416/1806-3756/e20220179